Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction.
Jiang C, Xie C, Lv Y, Li J, Krausz KW, Shi J, Brocker CN, Desai D, Amin SG, Bisson WH, Liu Y, Gavrilova O, Patterson AD, Gonzalez FJ.
Jiang C, et al. Among authors: amin sg.
Nat Commun. 2015 Dec 15;6:10166. doi: 10.1038/ncomms10166.
Nat Commun. 2015.
PMID: 26670557
Free PMC article.